FRANKLIN, Mass., April 18, 2018 /PRNewswire/ — Arthrosurface® announced today that The Company received FDA 510(k) Clearance to market the OVOMotion™ Shoulder Arthroplasty System. This stemless total shoulder system provides the surgeon with an approach that results in increased exposure to the glenoid, minimizes bone removal, and is designed for patients with painful and/or severely disabled shoulder joints resulting […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone